Cambiar Investors LLC Has $9.64 Million Position in Molina Healthcare, Inc. (NYSE:MOH)

Cambiar Investors LLC reduced its position in shares of Molina Healthcare, Inc. (NYSE:MOH) by 11.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,136 shares of the company’s stock after selling 4,193 shares during the period. Cambiar Investors LLC’s holdings in Molina Healthcare were worth $9,644,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Summit Trail Advisors LLC acquired a new position in shares of Molina Healthcare during the fourth quarter worth about $452,000. Wingate Wealth Advisors Inc. acquired a new position in shares of Molina Healthcare during the fourth quarter worth about $52,000. Savant Capital LLC acquired a new position in shares of Molina Healthcare during the fourth quarter worth about $225,000. Entropy Technologies LP boosted its position in shares of Molina Healthcare by 58.1% during the fourth quarter. Entropy Technologies LP now owns 4,594 shares of the company’s stock worth $1,337,000 after buying an additional 1,688 shares during the period. Finally, Empirical Finance LLC boosted its position in shares of Molina Healthcare by 53.8% during the fourth quarter. Empirical Finance LLC now owns 4,632 shares of the company’s stock worth $1,348,000 after buying an additional 1,621 shares during the period. 98.50% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. StockNews.com cut Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Barclays dropped their target price on Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a report on Friday. Stephens reiterated an “equal weight” rating and set a $345.00 target price on shares of Molina Healthcare in a report on Thursday, February 6th. Truist Financial dropped their target price on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a report on Thursday, October 24th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Molina Healthcare has a consensus rating of “Hold” and an average target price of $355.67.

Molina Healthcare Price Performance

NYSE:MOH opened at $286.20 on Tuesday. The company has a quick ratio of 1.55, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The stock’s 50 day moving average price is $297.96 and its two-hundred day moving average price is $318.27. The firm has a market capitalization of $16.37 billion, a price-to-earnings ratio of 14.01, a P/E/G ratio of 0.94 and a beta of 0.54. Molina Healthcare, Inc. has a 12-month low of $272.69 and a 12-month high of $423.92.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, analysts anticipate that Molina Healthcare, Inc. will post 24.5 earnings per share for the current year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.